Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
At week 52, 81% of subjects met a composite efficacy endpoint, 95% were able to stop conventional therapy, and none required active vitamin D
GIP receptor agonism amplifies insulin response, may reduce nausea at higher doses (a counterintuitive but documented effect), and appears to enhance the metabolic effects of GLP-1 agonism synergistically
Known as the "master antioxidant," glutathione is essential for protecting cells from oxidative stress and damage c
"Tirzepatide effectively reduced drive to eat, as well as food-cue-driven and other-cue-driven eating behavior." Nature Medicine This effect is due to tirzepatides action on both GIP and GLP-1 receptors, which slows gastric emptying, signals fullness to the brain, and improves insulin sensitivity
Many of our patients use multiple peptides to address different goals simultaneously
